{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:24:13Z","timestamp":1768037053172,"version":"3.49.0"},"reference-count":267,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.pcad.2007.11.003","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T19:08:28Z","timestamp":1204571308000},"page":"311-351","source":"Crossref","is-referenced-by-count":17,"title":["Contemporary Approach to the Diagnosis and Management of Non\u2013ST-Segment Elevation Acute Coronary Syndromes"],"prefix":"10.1016","volume":"50","author":[{"given":"William E.","family":"Boden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prediman K.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vipul","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Magnus","family":"Ohman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2007.11.003_bib1","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1056\/NEJM200106213442510","article-title":"Optimal treatment of acute coronary syndromes\u2014an evolving strategy","volume":"344","author":"Boden","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(02)02571-8","article-title":"Cardioprotective effects of an early routine invasive strategy for non\u2013ST-segment elevation acute coronary syndromes: are we all becoming \u201cinterventional\u201d cardiologists?","author":"Yarlagadda","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib3","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.CIR.89.4.1545","article-title":"Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non\u2013Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia","volume":"89","author":"Anderson","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib4","first-page":"1643","article-title":"One year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial: a randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non\u2013Q wave myocardial infarction","volume":"26","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib5","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199806183382501","article-title":"The Veterans Affairs Non\u2013Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. Outcomes in patients with acute non\u2013Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy","volume":"338","author":"Boden","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib6","series-title":"Heart and stroke facts: 2002 statistical update","author":"American Heart Association","year":"2001"},{"key":"10.1016\/j.pcad.2007.11.003_bib7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","volume":"354","author":"FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators: invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(00)02427-2","article-title":"Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomized trial","volume":"356","author":"Wallentin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib9","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib10","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","article-title":"Clinical benefits of platelet glycoprotein IIb\/IIIa blockade with coronary stenting in acute myocardial infarction","volume":"344","author":"Montalescot","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM199907293410503","article-title":"Complementary clinical benefits of coronary artery stenting and blockade of platelet glycoprotein IIb\/IIIa receptors","volume":"341","author":"Lincoff","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0735-1097(00)00923-2","article-title":"Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 PILOT) trial","volume":"36","author":"Herrmann","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib13","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.0000037106.76139.53","article-title":"ACC\/AHA guideline update for the management of patients with unstable angina and non\u2013ST-segment elevation myocardial infarction\u20142002: summary article","volume":"106","author":"Braunwald","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199201303260506","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes (2)","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.pcad.2007.11.003_bib15","doi-asserted-by":"crossref","first-page":"SII5","DOI":"10.1016\/S0140-6736(99)90234-9","article-title":"Acute coronary syndromes: biology","volume":"353","author":"Fuster","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.ATV.0000059303.94760.5C","article-title":"Suppression subtractive hybridization identifies distinctive expression markers for coronary and internal mammary arteries","volume":"23","author":"Qin","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2007.11.003_bib17","doi-asserted-by":"crossref","first-page":"14871","DOI":"10.1073\/pnas.0406073101","article-title":"Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature","volume":"101","author":"Dai","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pcad.2007.11.003_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.CIR.104.3.365","article-title":"Current concepts of the pathogenesis of the acute coronary syndromes","volume":"104","author":"Libby","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-134-3-200102060-00014","article-title":"Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences","volume":"134","author":"Rauch","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib21","first-page":"288A","article-title":"Internal elastic lamina in the process of plaque disruption","volume":"37","author":"Moreno","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF01660974","article-title":"Composition and classification of human atherosclerotic lesions","volume":"421","author":"Stary","year":"1992","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.pcad.2007.11.003_bib23","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1161\/01.CIR.94.8.2013","article-title":"Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White lecture 1995","volume":"94","author":"Davies","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.CIR.90.2.775","article-title":"Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture","volume":"90","author":"Moreno","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib25","series-title":"Syndromes of atherosclerosis: correlations of clinical imaging and pathology","first-page":"105","article-title":"Angiographic correlations of advanced coronary lesions in acute coronary syndromes","author":"Ambrose","year":"1996"},{"key":"10.1016\/j.pcad.2007.11.003_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1749-6632.2001.tb03940.x","article-title":"New understanding of atherosclerosis (clinically and experimentally) with evolving MRI technology in vivo","volume":"947","author":"Corti","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pcad.2007.11.003_bib27","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/01.CIR.102.10.1086","article-title":"Tissue endothelin-converting enzyme activity correlates with cardiovascular risk factors in coronary artery disease","volume":"102","author":"Ruschitzka","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00041433-200108000-00003","article-title":"Endothelial function and coronary artery disease","volume":"12","author":"Kinlay","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pcad.2007.11.003_bib29","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00041433-199608000-00010","article-title":"Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions","volume":"7","author":"Luscher","year":"1996","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pcad.2007.11.003_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.CIR.101.9.948","article-title":"Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction","volume":"101","author":"Suwaidi","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib32","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/01.CIR.101.16.1899","article-title":"Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease","volume":"101","author":"Schachinger","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/35097196","article-title":"Human genetics. To clot or not","volume":"413","author":"Fosang","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pcad.2007.11.003_bib34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib35","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/hh1001.090571","article-title":"Current perspective on the role of apoptosis in atherothrombotic disease","volume":"88","author":"Mallat","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2007.11.003_bib36","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1056\/NEJM199705013361802","article-title":"Coronary risk factors and plaque morphology in men with coronary disease who died suddenly","volume":"336","author":"Burke","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib37","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/0735-1097(94)90657-2","article-title":"Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture","volume":"23","author":"Fernandez-Ortiz","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib38","doi-asserted-by":"crossref","first-page":"594 9","DOI":"10.1161\/01.CIR.95.3.594","article-title":"Tissue factor modulates the thrombogenicity of human atherosclerotic plaques","volume":"95","author":"Toschi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib39","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1161\/01.CIR.90.5.2432","article-title":"Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy","volume":"90","author":"Meyer","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib40","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.CIR.90.4.2126","article-title":"Conner memorial lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology","volume":"90","author":"Fuster","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib41","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1253\/jcj.65.473","article-title":"Evolution and stabilization of vulnerable atherosclerotic plaques","volume":"65","author":"Libby","year":"2001","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.pcad.2007.11.003_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V71.1.1.1","article-title":"Tissue factor and hemostasis","volume":"71","author":"Nemerson","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.pcad.2007.11.003_bib43","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1161\/01.CIR.94.12.3090","article-title":"Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes","volume":"94","author":"Moreno","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib44","first-page":"36","article-title":"Pig coronary angioplasty is followed by the coordinated upregulation of tissue factor and caspase-3","volume":"37","author":"Hutter","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib45","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/01.CIR.99.14.1780","article-title":"Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions","volume":"99","author":"Badimon","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib46","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/S0735-1097(00)01018-4","article-title":"Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty","volume":"36","author":"Roque","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib47","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","article-title":"Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions","volume":"20","author":"Virmani","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2007.11.003_bib48","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0735-1097(99)00018-2","article-title":"Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile","volume":"33","author":"Dangas","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.CIR.102.6.602","article-title":"Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity","volume":"102","author":"Matetzky","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0021-9150(00)00397-X","article-title":"Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins","volume":"153","author":"Rauch","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pcad.2007.11.003_bib51","doi-asserted-by":"crossref","first-page":"IV94","DOI":"10.1161\/01.CIR.102.suppl_4.IV-94","article-title":"Risk reduction","volume":"102","author":"Fuster","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib52","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00041433-200112000-00006","article-title":"Value or desirability of hemorheological-hemostatic parameter changes as endpoints in blood lipid\u2013regulating trials","volume":"12","author":"Corti","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pcad.2007.11.003_bib53","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/01.CIR.98.6.528","article-title":"Cigarette smoking increases sympathetic outflow in humans","volume":"98","author":"Narkiewicz","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib54","first-page":"125","article-title":"The beauty and the beast: aspects of the autonomic nervous system","volume":"15","author":"Corti","year":"2000","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.pcad.2007.11.003_bib55","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0735-1097(01)01555-8","article-title":"Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control","volume":"38","author":"Osende","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib56","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9149(00)00871-7","article-title":"Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2","volume":"86","author":"Rauch","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib57","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2337\/diabetes.48.5.1156","article-title":"Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men","volume":"48","author":"Rao","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.pcad.2007.11.003_bib58","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/01.ATV.17.10.2232","article-title":"Tissue factor expression on macrophages in coronary plaques in patients with unstable angina","volume":"17","author":"Kaikita","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2007.11.003_bib59","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1096-8652(199908)61:4<238::AID-AJH3>3.0.CO;2-8","article-title":"Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease","volume":"61","author":"Saito","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pcad.2007.11.003_bib60","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.99.22.2908","article-title":"Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina","volume":"99","author":"Soejima","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib61","first-page":"291","article-title":"Tissue factor pathway inhibitor expression in atherosclerosis","volume":"77","author":"Drew","year":"1997","journal-title":"Lab Invest"},{"key":"10.1016\/j.pcad.2007.11.003_bib62","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1073\/pnas.96.5.2311","article-title":"Blood-borne tissue factor: another view of thrombosis","volume":"96","author":"Giesen","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pcad.2007.11.003_bib63","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","article-title":"High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib64","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.CIR.100.1.96","article-title":"C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?","volume":"100","author":"Lagrand","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib65","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/01.CIR.103.21.2531","article-title":"Modulation of C-reactive protein\u2013mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs","volume":"103","author":"Pasceri","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib66","doi-asserted-by":"crossref","first-page":"13768","DOI":"10.1073\/pnas.0706027104","article-title":"Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia","volume":"104","author":"Kovacs","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pcad.2007.11.003_bib67","article-title":"Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE(\u2212\/\u2212) mice","author":"Tennent","year":"2007","journal-title":"Atherosclerosis"},{"issue":"4 Suppl S","key":"10.1016\/j.pcad.2007.11.003_bib68","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1016\/S0735-1097(02)02834-6","article-title":"Mechanisms of plaque vulnerability and rupture","volume":"41","author":"Shah","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib69","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/pcad.2002.123473","article-title":"Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion","volume":"44","author":"Shah","year":"2002","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2007.11.003_bib70","doi-asserted-by":"crossref","first-page":"114E","DOI":"10.1016\/0002-9149(89)90242-7","article-title":"Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes","volume":"63","author":"Falk","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib71","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/hrt.50.2.127","article-title":"Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi","volume":"50","author":"Falk","year":"1983","journal-title":"Br Heart J"},{"key":"10.1016\/j.pcad.2007.11.003_bib72","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM198405033101801","article-title":"Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death","volume":"310","author":"Davies","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib73","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.66.2.316","article-title":"Significance of the angiographic morphology of localized coronary stenoses: histopathologic correlations","volume":"66","author":"Levin","year":"1982","journal-title":"Circulation"},{"issue":"6 Suppl","key":"10.1016\/j.pcad.2007.11.003_bib74","first-page":"III34","article-title":"The pathogenesis of coronary plaques, thromboses, and hemorrhages: an evaluative review","volume":"52","author":"Friedman","year":"1975","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib75","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1161\/01.ATV.17.7.1337","article-title":"Relation of plaque lipid composition and morphology to the stability of human aortic plaques","volume":"17","author":"Felton","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2007.11.003_bib76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0021-9150(92)90039-J","article-title":"Collagen types I and III, collagen content, GAGs and mechanical strength of human atherosclerotic plaque caps: span-wise variations","volume":"96","author":"Burleigh","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pcad.2007.11.003_bib77","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1540-8183.2002.tb01087.x","article-title":"Vulnerable plaque: the pathology of unstable coronary lesions","volume":"15","author":"Virmani","year":"2002","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib78","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0735-1097(85)80207-2","article-title":"Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction","volume":"6","author":"Ambrose","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib79","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1172\/JCI117619","article-title":"Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques","volume":"94","author":"Galis","year":"1994","journal-title":"J Clin Invest"},{"issue":"11 Suppl 2","key":"10.1016\/j.pcad.2007.11.003_bib80","first-page":"II38","article-title":"Plaque disruption and coronary thrombosis: new insight into pathogenesis and prevention","volume":"20","author":"Shah","year":"1997","journal-title":"Clin Cardiol"},{"issue":"4 Suppl S","key":"10.1016\/j.pcad.2007.11.003_bib81","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1016\/S0735-1097(02)02833-4","article-title":"Pathogenetic concepts of acute coronary syndromes","volume":"41","author":"Corti","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib82","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0741-5214(03)00709-2","article-title":"High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque","volume":"38","author":"Alvarez Garcia","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2007.11.003_bib83","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/01.CIR.79.4.733","article-title":"Circadian variation and triggers of onset of acute cardiovascular disease","volume":"79","author":"Muller","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib84","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000174480","article-title":"Morning increase of onset of myocardial infarction. Implications concerning triggering events","volume":"76","author":"Muller","year":"1989","journal-title":"Cardiology"},{"key":"10.1016\/j.pcad.2007.11.003_bib85","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/1047-2797(92)90088-8","article-title":"Triggering and hourly variation of onset of arterial thrombosis","volume":"2","author":"Muller","year":"1992","journal-title":"Ann Epidemiol"},{"issue":"Suppl 1","key":"10.1016\/j.pcad.2007.11.003_bib86","first-page":"S73","article-title":"Pathophysiology and triggers of acute myocardial infarction: clinical implications","volume":"70","author":"Willich","year":"1992","journal-title":"Clin Investig"},{"key":"10.1016\/j.pcad.2007.11.003_bib87","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/01.CIR.87.5.1442","article-title":"Sudden cardiac death. Support for a role of triggering in causation","volume":"87","author":"Willich","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib88","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1161\/01.CIR.103.23.2810","article-title":"Increased particulate air pollution and the triggering of myocardial infarction","volume":"103","author":"Peters","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib89","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/01.CIR.103.23.2805","article-title":"Triggering myocardial infarction by marijuana","volume":"103","author":"Mittleman","year":"2001","journal-title":"Circulation"},{"issue":"4 Pt. 2","key":"10.1016\/j.pcad.2007.11.003_bib90","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0002-8703(99)70390-X","article-title":"Circadian variation and triggering of acute coronary events","volume":"137","author":"Muller","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2007.11.003_bib91","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0002-9149(00)00885-7","article-title":"Triggering of cardiac events by sexual activity: findings from a case-crossover analysis","volume":"86","author":"Muller","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib92","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM200009283431303","article-title":"Multiple complex coronary plaques in patients with acute myocardial infarction","volume":"343","author":"Goldstein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib93","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/01.CIR.0000025609.13806.31","article-title":"Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study","volume":"106","author":"Rioufol","year":"2002","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1016\/j.pcad.2007.11.003_bib94","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/0021-9150(95)90081-0","article-title":"Vulnerable and dangerous coronary plaques","volume":"118","author":"Schroeder","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pcad.2007.11.003_bib95","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00045415-200008010-00007","article-title":"Plaque disruption and thrombosis: potential role of inflammation and infection","volume":"8","author":"Shah","year":"2000","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.pcad.2007.11.003_bib96","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/01.CIR.0000025708.36290.05","article-title":"Plaque vulnerability, plaque rupture, and acute coronary syndromes: (multi)-focal manifestation of a systemic disease process","volume":"106","author":"Schoenhagen","year":"2002","journal-title":"Circulation"},{"issue":"4 Suppl S","key":"10.1016\/j.pcad.2007.11.003_bib97","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0735-1097(02)02953-4","article-title":"C-reactive protein and other inflammatory risk markers in acute coronary syndromes","volume":"41","author":"Blake","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib98","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1001\/jama.286.17.2154","article-title":"Inflammatory markers in coronary artery disease: let prevention douse the flames","volume":"286","author":"Vorchheimer","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib99","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7326\/0003-4819-130-11-199906010-00018","article-title":"Evaluating novel cardiovascular risk factors: can we better predict heart attacks","volume":"130","author":"Ridker","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.CIR.90.1.583","article-title":"Myocardial infarction and coronary deaths in the World Health Organization project: registration procedures, event rates, and case-fatality rates in 39 populations from 21 countries in four continents","volume":"90","author":"Tunstall-Pedoe","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib101","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology\/American College of Cardiology Committee for the Redefinition of Myocardial Infarction","volume":"36","author":"Alpert","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib102","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.STR.0000260091.13729.96","article-title":"Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke","volume":"38","author":"Rivera","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.pcad.2007.11.003_bib103","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1373\/clinchem.2005.064857","article-title":"The antibody configurations of cardiac troponin I assays may determine their clinical performance","volume":"52","author":"James","year":"2006","journal-title":"Clin Chem"},{"issue":"4 Suppl S","key":"10.1016\/j.pcad.2007.11.003_bib104","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1016\/S0735-1097(02)02832-2","article-title":"Troponin: an important prognostic marker and risk-stratification tool in non\u2013ST-segment elevation acute coronary syndromes","volume":"41","author":"Newby","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(00)00889-5","article-title":"ACC\/AHA guidelines for the management of patients with unstable angina and non\u2013ST-segment elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)","volume":"36","author":"Braunwald","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib106","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM199610313351801","article-title":"Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators","volume":"335","author":"Ohman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib107","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/01.CIR.93.9.1651","article-title":"Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease","volume":"93","author":"Lindahl","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib108","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.313.7052.262","article-title":"Prospective study of the role of cardiac troponin T in patients admitted with unstable angina","volume":"313","author":"Stubbs","year":"1996","journal-title":"Br Med J"},{"key":"10.1016\/j.pcad.2007.11.003_bib109","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","article-title":"Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes","volume":"335","author":"Antman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib110","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1161\/01.CIR.98.18.1853","article-title":"Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes","volume":"98","author":"Newby","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib111","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9149(98)00200-8","article-title":"Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies","volume":"81","author":"Ilatidoye","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib112","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mhj.2000.111107","article-title":"Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes","volume":"140","author":"Ottani","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2007.11.003_bib113","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.100.14.1509","article-title":"Angiographic findings in patients with refractory unstable angina according to troponin T status","volume":"100","author":"Heeschen","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib114","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1161\/01.CIR.103.24.2891","article-title":"Benefit of glycoprotein IIb\/IIIa inhibition in patients with acute coronary syndromes and troponin T\u2013positive status: the PARAGON-B Troponin T Substudy","volume":"103","author":"Newby","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib115","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(00)05060-1","article-title":"Effect of glycoprotein IIb\/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV\u2013ACS randomised trial","volume":"357","author":"GUSTO IV-ACS Investigators","year":"2001","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.pcad.2007.11.003_bib116","first-page":"I663","article-title":"Cardiac troponin I on admission predicts death by 42 days in unstable angina and improved survival with an early invasive strategy: results from TIMI IIIB","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1016\/j.pcad.2007.11.003_bib117","first-page":"I810","article-title":"Is the adverse outcome with positive troponin T neutralized by revascularization? Results from GUSTO-IIa","volume":"100","author":"Goldmann","year":"1999","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1016\/j.pcad.2007.11.003_bib118","first-page":"469","article-title":"Invasive vs non-invasive strategy in relation to troponin T level and ECG findings\u2014a FRISC-2 substudy","volume":"21","author":"Lindahl","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2007.11.003_bib119","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/hh2101.099270","article-title":"Novel clinical markers of vascular wall inflammation","volume":"89","author":"Blake","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2007.11.003_bib120","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.103.9.1194","article-title":"C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis","volume":"103","author":"Zwaka","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib121","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/1043-4666(92)90079-7","article-title":"Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein","volume":"4","author":"Ballou","year":"1992","journal-title":"Cytokine"},{"key":"10.1016\/j.pcad.2007.11.003_bib122","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","article-title":"Direct proinflammatory effect of C-reactive protein on human endothelial cells","volume":"102","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib123","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0002-9440(10)64051-5","article-title":"Generation of C-reactive protein and complement components in atherosclerotic plaques","volume":"158","author":"Yasojima","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pcad.2007.11.003_bib124","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/oxfordjournals.aje.a008963","article-title":"Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial","volume":"144","author":"Kuller","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","article-title":"C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg cohort study, 1984 to 1992","volume":"99","author":"Koenig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib126","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.CIR.98.8.731","article-title":"Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib127","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib128","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.ATV.17.6.1121","article-title":"Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project","volume":"17","author":"Tracy","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2007.11.003_bib129","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib130","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib131","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","article-title":"Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease","volume":"285","author":"Ridker","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib132","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses","volume":"321","author":"Danesh","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.pcad.2007.11.003_bib133","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.ATV.21.4.603","article-title":"C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?","volume":"21","author":"Lowe","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2007.11.003_bib134","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib135","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0735-1097(98)00136-3","article-title":"C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis In Myocardial Infarction","volume":"31","author":"Morrow","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib136","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0735-1097(00)00581-7","article-title":"Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial","volume":"35","author":"Heeschen","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib137","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","article-title":"Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease","volume":"343","author":"Lindahl","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib138","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1161\/01.CIR.98.22.2370","article-title":"Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina","volume":"98","author":"Liuzzo","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib139","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1161\/01.CIR.99.16.2079","article-title":"Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events","volume":"99","author":"Biasucci","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib140","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1001\/jama.286.17.2107","article-title":"Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy","volume":"286","author":"Lindmark","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib141","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa011053","article-title":"The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes","volume":"345","author":"De Lemos","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib142","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.103.3.357","article-title":"Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study","volume":"103","author":"Freeman","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib143","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7326\/0003-4819-130-11-199906010-00018","article-title":"Evaluating novel cardiovascular risk factors: can we better predict heart attacks?","volume":"130","author":"Ridker","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib144","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.97.20.2007","article-title":"C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib145","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/hc3401.095074","article-title":"Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention","volume":"104","author":"Chew","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib146","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM200111083451911","article-title":"Locking a leukocyte integrin with statins","volume":"345","author":"Frenette","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib147","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels. The Pravastatin Inflammation\/CRP Evaluation (PRINCE): a randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib148","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.103.15.1933","article-title":"Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels","volume":"103","author":"Jialal","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib149","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","article-title":"Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol And Recurrent Events (CARE) Investigators","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib150","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.CIR.103.9.1191","article-title":"Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib151","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib152","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non\u2013Q-wave myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trial","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib153","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular weight heparin with unfractionated heparin for unstable coronary artery disease","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib154","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"The Platelet Receptor inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non\u2013Q-wave myocardial infarction","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib155","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with in patients with acute coronary syndromes","volume":"339","author":"The PURSUIT Trial Investigators","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib156","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non\u2013ST-elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib157","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/01.CIR.101.22.2557","article-title":"Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators","volume":"101","author":"Boersma","year":"2000","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1016\/j.pcad.2007.11.003_bib158","first-page":"I432","article-title":"Diabetes mellitus is associated with worse clinical outcomes across the spectrum of acute coronary syndromes: results from GUSTO-IIb","volume":"100","author":"McGuire","year":"1999","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1016\/j.pcad.2007.11.003_bib159","first-page":"410","article-title":"Prior peripheral vascular disease and cerebrovascular disease are independent predictors of increased 1 year mortality in patients with acute coronary syndromes: results from OPUS-TIMI 16","volume":"35","author":"Cotter","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib160","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/0735-1097(95)00009-S","article-title":"Incidence and follow-up of Braunwald subgroups in unstable angina pectoris","volume":"25","author":"Van Miltenburg-van Zijl","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib161","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0002-9149(99)00049-1","article-title":"Prior aspirin use predicts worse outcomes in patients with non\u2013ST-segment elevation acute coronary syndromes","volume":"83","author":"Alexander","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib162","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/01.STR.25.12.2331","article-title":"Development of aspirin resistance in persons with previous ischemic stroke","volume":"25","author":"Helgason","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.pcad.2007.11.003_bib163","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0140-6736(99)00498-5","article-title":"Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance","volume":"353","author":"Weber","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib164","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0735-1097(97)00160-5","article-title":"The electrocardiogram predicts one-year outcome of patients with unstable angina and non\u2013Q-wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study","volume":"30","author":"Cannon","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib165","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.281.8.707","article-title":"Prognostic value of the admission electrocardiogram in acute coronary syndromes","volume":"281","author":"Savonitto","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib166","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0002-9149(99)00319-7","article-title":"Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression","volume":"84","author":"Hyde","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib167","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0735-1097(95)00404-1","article-title":"One-year results of the Thrombolysis In Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non\u2013Q-wave myocardial infarction","volume":"26","author":"Anderson","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib168","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","article-title":"Unstable angina. A classification","volume":"80","author":"Braunwald","year":"1989","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1016\/j.pcad.2007.11.003_bib169","first-page":"I19","article-title":"Prospective validation of the Braunwald classification of unstable angina: results from the Thrombolysis In Myocardial Infarction (TIMI) III Registry","volume":"92","author":"Cannon","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jama.273.2.136","article-title":"Risk stratification in unstable angina. Prospective validation of the Braunwald classification","volume":"273","author":"Calvin","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib171","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non\u2013Q-wave myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trial","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib172","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1067\/mhj.2002.122870","article-title":"Identification of patients at high risk for death and cardiac ischemic events after hospital discharge","volume":"143","author":"Sabatine","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2007.11.003_bib173","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":"Guidelines for the diagnosis and treatment of non\u2013ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non\u2013ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology","volume":"28","author":"Bassand","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2007.11.003_bib174","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.CIR.100.1.14","article-title":"Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial","volume":"100","author":"Berger","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib175","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1001\/jama.283.22.2941","article-title":"Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction","volume":"283","author":"Cannon","year":"2000","journal-title":"JAMA"},{"issue":"4 Suppl S","key":"10.1016\/j.pcad.2007.11.003_bib176","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/S0735-1097(02)03017-6","article-title":"Introduction to \u201coptimizing management of non\u2013ST-segment elevation acute coronary syndromes\u201d. Harmonizing advances in mechanical and pharmacologic intervention","volume":"41","author":"Boden","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"4 Suppl S","key":"10.1016\/j.pcad.2007.11.003_bib177","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1016\/S0735-1097(02)02835-8","article-title":"Glycoprotein IIb\/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGET","volume":"41","author":"Moliterno","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"4 Suppl S","key":"10.1016\/j.pcad.2007.11.003_bib178","doi-asserted-by":"crossref","first-page":"79S","DOI":"10.1016\/S0735-1097(02)02831-0","article-title":"Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention","volume":"41","author":"Mehta","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib179","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.pcad.2007.11.003_bib180","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJM198806303182603","article-title":"Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty","volume":"318","author":"Schwartz","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib181","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1161\/01.CIR.92.11.3194","article-title":"Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II)","volume":"92","author":"Savage","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib182","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1053\/euhj.2000.2474","article-title":"Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study Investigators. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease","volume":"21","author":"Mehta","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2007.11.003_bib183","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib184","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/01.CIR.0000029926.71825.E2","article-title":"Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups","volume":"106","author":"Budaj","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib185","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1161\/01.ATV.20.10.2316","article-title":"Acute antithrombotic effect of a front-loaded regimen of clopidogrel in patients with atherosclerosis on aspirin","volume":"20","author":"Helft","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2007.11.003_bib186","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib187","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0002-8703(03)00104-2","article-title":"What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?","volume":"145","author":"Steinhubl","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2007.11.003_bib188","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib189","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","article-title":"A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib190","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","article-title":"Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib191","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb\/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib192","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(98)11086-3","article-title":"Platelet GPIIb-IIIa blockers","volume":"353","author":"Topol","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib193","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/01.CIR.98.25.2829","article-title":"Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb\/IIIa integrin in ischemic heart disease","volume":"98","author":"Kong","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib194","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.100.20.2045","article-title":"Platelet glycoprotein IIb\/IIIa receptor inhibition in non\u2013ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention","volume":"100","author":"Boersma","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib195","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(00)05060-1","article-title":"GUSTO IV\u2013ACS Investigators. Effect of glycoprotein IIb\/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV\u2013ACS randomised trial","volume":"357","author":"Simoons","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib196","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.CIR.97.24.2386","article-title":"International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb\/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb\/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network","volume":"97","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib197","unstructured":"Harrington, R. Optimal dosing of a platelet glycoprotein antagonist, lamifiban, using renal-based algorithms, in patients with acute coronary syndromes: results from the PARAGON-B study. [abstract] 2000."},{"key":"10.1016\/j.pcad.2007.11.003_bib198","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/01.CIR.103.10.1403","article-title":"Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb\/IIIa Inhibitor for Stenting (EPISTENT) Trial","volume":"103","author":"Steinhubl","year":"2001","journal-title":"Circulation"},{"issue":"4 Suppl S","key":"10.1016\/j.pcad.2007.11.003_bib199","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1016\/S0735-1097(02)03018-8","article-title":"Small molecule glycoprotein IIb\/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial","volume":"41","author":"Cannon","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.CIR.103.2.201","article-title":"Increased mortality with oral platelet glycoprotein IIb\/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials","volume":"103","author":"Chew","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib201","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.276.10.811","article-title":"Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis","volume":"276","author":"Oler","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib202","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.96.1.61","article-title":"Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)","volume":"96","author":"Klein","year":"1997","journal-title":"Circulation"},{"issue":"5 Suppl","key":"10.1016\/j.pcad.2007.11.003_bib203","doi-asserted-by":"crossref","first-page":"489S","DOI":"10.1378\/chest.114.5_Supplement.489S","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety","volume":"114","author":"Hirsh","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.pcad.2007.11.003_bib204","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low-molecular-weight heparins","volume":"337","author":"Weitz","year":"1997","journal-title":"N Engl J Med"},{"issue":"4 Suppl S","key":"10.1016\/j.pcad.2007.11.003_bib205","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1016\/S0735-1097(02)02901-7","article-title":"The role of low-molecular-weight heparin in the management of acute coronary syndromes","volume":"41","author":"Cohen","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.pcad.2007.11.003_bib206","first-page":"14","article-title":"Can we differentiate the low-molecular-weight heparins","volume":"23","author":"Turpie","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib207","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1001\/jama.270.14.1672","article-title":"From the Food and Drug Administration","volume":"270","author":"Nightingale","year":"1993","journal-title":"JAMA"},{"issue":"Suppl 3","key":"10.1016\/j.pcad.2007.11.003_bib208","first-page":"113","article-title":"Low molecular weight heparins in the management of unstable angina\/non\u2013Q-wave myocardial infarction","volume":"25","author":"Cohen","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pcad.2007.11.003_bib209","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0167-5273(99)00171-0","article-title":"Combination therapy with tirofiban and enoxaparin in acute coronary syndromes","volume":"71","author":"Cohen","year":"1999","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib210","unstructured":"Cohen M, Theroux P, Frey MJ. et al. Anti-thrombotic combination using tirofiban and enoxaparin: the ACUTE II study. 1471. 2000"},{"key":"10.1016\/j.pcad.2007.11.003_bib211","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.CIR.0000050144.67910.13","article-title":"Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non\u2013ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb\/IIIa inhibitor eptifibatide","volume":"107","author":"Goodman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib212","first-page":"272","article-title":"Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention","volume":"13","author":"Kereiakes","year":"2001","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib213","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/01.CIR.103.5.658","article-title":"Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris","volume":"103","author":"Collet","year":"2001","journal-title":"Circulation"},{"issue":"Suppl E","key":"10.1016\/j.pcad.2007.11.003_bib214","first-page":"E10","article-title":"Combining low-molecular-weight heparin and glycoprotein IIb\/IIIa antagonists for the treatment of acute coronary syndromes: the NICE 3 story. National Investigators Collaborating on Enoxaparin","volume":"12","author":"Ferguson","year":"2000","journal-title":"J Invasive Cardiol"},{"issue":"Suppl E","key":"10.1016\/j.pcad.2007.11.003_bib215","first-page":"E14","article-title":"Low-molecular-weight heparin therapy in percutaneous coronary intervention: the NICE 1 and NICE 4 trials. National Investigators Collaborating on Enoxaparin Investigators","volume":"12","author":"Young","year":"2000","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib216","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib217","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)85010-1","article-title":"Randomised placebo-controlled and balloon-angioplasty\u2013controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade. Evaluation of Platelet IIb\/IIIa Inhibitor for Stenting","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"4 Suppl S","key":"10.1016\/j.pcad.2007.11.003_bib218","doi-asserted-by":"crossref","first-page":"70S","DOI":"10.1016\/S0735-1097(02)02687-6","article-title":"The evolving role of direct thrombin inhibitors in acute coronary syndromes","volume":"41","author":"Eikelboom","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib219","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(02)07495-0","article-title":"Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib220","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(07)60450-4","article-title":"Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial","volume":"369","author":"Gregg","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib221","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jama.292.6.696","article-title":"Long-term efficacy of bivalirudin and provisional glycoprotein IIb\/IIIa blockade vs heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary revascularization","volume":"292","author":"Lincoff","year":"2004","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.pcad.2007.11.003_bib222","first-page":"11","article-title":"Past, present and future of hirudin","volume":"21","author":"Markwardt","year":"1991","journal-title":"Haemostasis"},{"key":"10.1016\/j.pcad.2007.11.003_bib223","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-2007-999007","article-title":"Hirudins: from leeches to man","volume":"22","author":"Wallis","year":"1996","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pcad.2007.11.003_bib224","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(98)07332-2","article-title":"Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib225","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1161\/01.CIR.100.20.2049","article-title":"Clinical outcomes of bivalirudin for ischemic heart disease","volume":"100","author":"Kong","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib226","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(01)06887-8","article-title":"Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial","volume":"358","author":"White","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib227","doi-asserted-by":"crossref","first-page":"12P","DOI":"10.1016\/S0002-9149(98)00660-2","article-title":"Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin","volume":"82","author":"Bates","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib228","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib229","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/jama.293.3.349","article-title":"A simplified approach to the management of non\u2013ST-segment elevation acute coronary syndromes","volume":"293","author":"Gluckman","year":"2005","journal-title":"JAMA"},{"issue":"16 Suppl 1","key":"10.1016\/j.pcad.2007.11.003_bib230","first-page":"28III","article-title":"Application of current guidelines to the management of unstable angina and non\u2013ST-elevation myocardial infarction","volume":"108","author":"Braunwald","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib231","doi-asserted-by":"crossref","first-page":"18A","DOI":"10.1016\/0002-9149(87)90494-2","article-title":"Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine\/metoprolol Trial (HINT)","volume":"60","author":"Lubsen","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib232","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0002-9149(91)90458-W","article-title":"Usefulness of esmolol in unstable angina pectoris. European Esmolol Study Group","volume":"67","author":"Hohnloser","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib233","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/bmj.299.6709.1187","article-title":"Calcium channel blockers in acute myocardial infarction and unstable angina: an overview","volume":"299","author":"Held","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.pcad.2007.11.003_bib234","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0002-9149(86)90727-7","article-title":"Comparison of verapamil and propranolol therapy for angina pectoris at rest: a randomized, multiple-crossover, controlled trial in the coronary care unit","volume":"57","author":"Parodi","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib235","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib236","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(00)04257-4","article-title":"Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study","volume":"357","author":"Aronow","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib237","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Pravastatin or Atorvastatin Evaluation and Infection Therapy\u2013Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib238","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non\u2013ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib239","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib240","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib241","first-page":"1","article-title":"Interventional versus conservative treatment for patients with unstable angina or non\u2013ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial","author":"Fox","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib242","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.290.12.1593","article-title":"Evaluation of prolonged antithrombotic pretreatment (\u201ccooling-off\u201d strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial","volume":"290","author":"Neumann","year":"2003","journal-title":"JAMA"},{"issue":"4 Suppl S","key":"10.1016\/j.pcad.2007.11.003_bib243","doi-asserted-by":"crossref","first-page":"96S","DOI":"10.1016\/S0735-1097(02)02688-8","article-title":"\u201cIschemia-guided\u201d versus \u201cearly invasive\u201d strategies in the management of acute coronary syndrome\/non\u2013ST-segment elevation myocardial infarction: the interventionalist's perspective","volume":"41","author":"McKay","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"4 Suppl S","key":"10.1016\/j.pcad.2007.11.003_bib244","doi-asserted-by":"crossref","first-page":"103S","DOI":"10.1016\/S0735-1097(02)02775-4","article-title":"Pathobiology, not angiography, should guide management in acute coronary syndrome\/non\u2013ST-segment elevation myocardial infarction: the non-interventionist's perspective","volume":"41","author":"Nissen","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib245","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/jama.286.19.2405","article-title":"TACTICS-TIMI 18 Investigators. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non\u2013ST elevation myocardial infarction: results from a randomized trial","volume":"286","author":"Morrow","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib246","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(02)09894-X","article-title":"Interventional versus conservative treatment for patients with unstable angina or non\u2013ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial","volume":"360","author":"Fox","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2007.11.003_bib247","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199907083410202","article-title":"Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib248","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa044259","article-title":"Early invasive versus selectively invasive management for acute coronary syndromes","volume":"353","author":"DeWinter","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2007.11.003_bib249","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1001\/jama.293.23.2908","article-title":"Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials","volume":"293","author":"Mehta","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2007.11.003_bib250","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.amjcard.2005.02.004","article-title":"Relation of timing of cardiac catheterization to outcomes in patients with non\u2013ST-segment elevation myocardial infarction or unstable angina pectoris enrolled in the multinational Global Registry of Acute Coronary Events","volume":"95","author":"Montalescot","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib251","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004815.pub2","article-title":"Early invasive versus conservative strategies for unstable angina and non\u2013ST-elevation myocardial infarction in the stent era","author":"Hoenig","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pcad.2007.11.003_bib252","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2007.02.028","article-title":"ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non\u2013ST-elevation myocardial infarction. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"4 Suppl S","key":"10.1016\/j.pcad.2007.11.003_bib253","doi-asserted-by":"crossref","first-page":"113S","DOI":"10.1016\/S0735-1097(02)02963-7","article-title":"\u201cRoutine invasive\u201d versus \u201cselective invasive\u201d approaches to non\u2013ST-segment elevation acute coronary syndromes management in the post-stent\/platelet inhibition era","volume":"41","author":"Boden","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl II","key":"10.1016\/j.pcad.2007.11.003_bib254","first-page":"II 745","article-title":"Impact of optimal adherence to comprehensive guideline-based management on in-hospital outcomes in high-risk patients with non\u2013ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative","volume":"112","author":"Boden","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib255","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.7326\/0003-4819-129-12-199812150-00010","article-title":"Vulnerable plaque: pathobiology and clinical implications","volume":"129","author":"Kullo","year":"1998","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.pcad.2007.11.003_bib256","first-page":"102","article-title":"Insights into the pathogenetic mechanisms of unstable angina","volume":"20","author":"Cohen","year":"1990","journal-title":"Haemostasis"},{"key":"10.1016\/j.pcad.2007.11.003_bib257","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib258","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/01.CIR.97.24.2433","article-title":"Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization","volume":"97","author":"Aikawa","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib259","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0735-1097(93)90051-2","article-title":"Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions","volume":"22","author":"Hambrecht","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib260","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0002-9149(94)90222-4","article-title":"Characteristics of conditioned and sedentary men with acute coronary syndromes","volume":"73","author":"Ciampricotti","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib261","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1067\/mhj.2002.122871","article-title":"Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study","volume":"143","author":"Murabito","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2007.11.003_bib262","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/01.CIR.86.3.828","article-title":"Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography. Relation to clinical events and risk factors. The INTACT Study Group","volume":"86","author":"Lichtlen","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2007.11.003_bib263","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2007.11.003_bib264","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0735-1097(99)00150-3","article-title":"ACC\/AHA\/ACP\u2013ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)","volume":"33","author":"Gibbons","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2007.11.003_bib265","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00045415-200103000-00008","article-title":"ABCs of cardiovascular disease risk management","volume":"9","author":"Braunstein","year":"2001","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.pcad.2007.11.003_bib266","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2165\/00129784-200202030-00004","article-title":"Perspectives of drug-eluting stents: the next revolution","volume":"2","author":"Moses","year":"2002","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.pcad.2007.11.003_bib267","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00129784-200303030-00007","article-title":"The sirolimus-eluting stent: a review of its use in the treatment of coronary artery disease","volume":"3","author":"McKeage","year":"2003","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062007001120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062007001120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T14:14:43Z","timestamp":1588428883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062007001120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":267,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0033062007001120"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2007.11.003","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}